Study of Bulevirtide in Participants With Chronic Hepatitis D Infection

Study Summary

The main goal of this study is to collect post marketing data from patients with chronic hepatitis D virus (HDV) infection who are treated with bulevirtide to describe the long-term effects of bulevirtide treatment and evaluate the safety of participants treated with bulevirtide.

Conditions

Chronic Hepatitis D Infection

Interventions / Drugs

Bulevirtide

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment170 participants

Primary Completion—

Lead SponsorGilead Sciences

Data Retrieved2026-04-11 02:55:27.113347+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.